Validation of a Proteomic-Based Prognostic Model for Breast Cancer and Immunological Analysis
Breast cancer (BC) has emerged as an extremely destructive malignancy, causing significant harm to female patients and society at large. Proteomic research holds great promise for early diagnosis and treatment of diseases, and the integration of proteomics with genomics can offer valuable assistance...
Saved in:
| Main Authors: | Yunlin Yu, Linhuan Dong, Changjun Dong, Xianlin Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | International Journal of Genomics |
| Online Access: | http://dx.doi.org/10.1155/2023/1738750 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systematic pan-cancer analysis identified NCOA4 as an immunological and prognostic biomarker and validated in lung adenocarcinoma
by: An Wang, et al.
Published: (2025-07-01) -
Multiomic characterization, immunological and prognostic potential of SMAD3 in pan-cancer and validation in LIHC
by: Tao Zhou, et al.
Published: (2025-01-01) -
Comprehensive analysis of the prognostic, immunological, and diagnostic roles of SIRT1 in pan-cancer and its validation in KIRC
by: Qi Liu, et al.
Published: (2025-01-01) -
Integrating bioinformatics with experimental validation unveils immunological and prognostic significance of PVRIG in pan-cancer
by: Peng Ma, et al.
Published: (2025-04-01) -
Identification of cell adhesion-related subtypes and construction of risk model to predict breast cancer prognostic and immunological properties
by: De-Ming Lv, et al.
Published: (2025-04-01)